secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2026-06-24T20:01:11+00:00
Accession:  0001628280-26-045154
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics reports 2026 annual meeting voting results; all proposals pass
--------------------------------------------------------------------------------

- Director nominees elected: Cole (35.1M for, 11.0M against), Gill (46.0M for), Parshall (44.4M for).
- Ratification of Deloitte & Touche as auditor for FY2026 approved with 51.7M votes for.
- Advisory vote on executive compensation approved with 45.6M for vs 0.5M against.
- Stockholders recommended 1-year frequency for future say-on-pay votes (45.6M for one year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/0001628280-26-045154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/fhtx-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-045154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer